ATE124994T1 - Physiologisch aktives polypeptid und dna. - Google Patents

Physiologisch aktives polypeptid und dna.

Info

Publication number
ATE124994T1
ATE124994T1 AT90104021T AT90104021T ATE124994T1 AT E124994 T1 ATE124994 T1 AT E124994T1 AT 90104021 T AT90104021 T AT 90104021T AT 90104021 T AT90104021 T AT 90104021T AT E124994 T1 ATE124994 T1 AT E124994T1
Authority
AT
Austria
Prior art keywords
edema
activity
physiologically active
polypeptide
active polypeptide
Prior art date
Application number
AT90104021T
Other languages
English (en)
Inventor
Tetsuji C O Daiichi Pure Sudoh
Keiji C O Daiichi Phar Maekawa
Naoto Minamino
Kenji Kangawa
Hisayuki Matsuo
Atsushi C O Daiichi Pure Izumi
Narihira
Mika C O Daiichi Pur Takashima
Original Assignee
Daiichi Pure Chemicals Co Ltd
Daiichi Seiyaku Co
Hisayuki Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26390052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE124994(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP04963689A external-priority patent/JP3160276B2/ja
Priority claimed from JP1059183A external-priority patent/JP2883903B2/ja
Application filed by Daiichi Pure Chemicals Co Ltd, Daiichi Seiyaku Co, Hisayuki Matsuo filed Critical Daiichi Pure Chemicals Co Ltd
Application granted granted Critical
Publication of ATE124994T1 publication Critical patent/ATE124994T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90104021T 1989-03-01 1990-03-01 Physiologisch aktives polypeptid und dna. ATE124994T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP04963689A JP3160276B2 (ja) 1989-03-01 1989-03-01 新規ｃＤＮＡフラグメント
JP1059183A JP2883903B2 (ja) 1989-03-10 1989-03-10 新規生理活性ペプチド及びその用途

Publications (1)

Publication Number Publication Date
ATE124994T1 true ATE124994T1 (de) 1995-07-15

Family

ID=26390052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104021T ATE124994T1 (de) 1989-03-01 1990-03-01 Physiologisch aktives polypeptid und dna.

Country Status (6)

Country Link
EP (1) EP0385476B2 (de)
AT (1) ATE124994T1 (de)
CL (1) CL2004001266A1 (de)
DE (1) DE69020755T3 (de)
DK (1) DK0385476T4 (de)
ES (1) ES2076981T5 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6028055A (en) * 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US6833358B1 (en) 1998-09-28 2004-12-21 Santen Pharmaceutical Co., Ltd. Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides
WO2004047871A2 (en) 2002-11-26 2004-06-10 Nobex Corporation Modified naturetic compounds, conjugates, and uses thereof
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
BRPI0709427A2 (pt) 2006-03-30 2011-07-12 Palatin Technologies Inc "construto cìclico, composição farmacêutica e uso de um composto
JP2009532385A (ja) 2006-03-30 2009-09-10 パラティン・テクノロジーズ・インコーポレーテッド 線状ナトリウム利尿ペプチド構築物
EP2197473A2 (de) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Therapeutische verwendung des b-typ natriuretischen peptids und humanen wachstumshormons 1-43
PL409596A1 (pl) * 2014-09-25 2016-03-29 Uniwersytet Wrocławski Pochodne pseudofaktyny, sposób otrzymywania pochodnych pseudofaktyny oraz ich zastosowanie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
EP0385476B1 (de) 1995-07-12
DK0385476T4 (da) 1999-12-20
EP0385476A1 (de) 1990-09-05
DK0385476T3 (da) 1995-10-02
EP0385476B2 (de) 1999-09-22
ES2076981T5 (es) 2000-02-01
ES2076981T3 (es) 1995-11-16
DE69020755T2 (de) 1996-04-04
DE69020755D1 (de) 1995-08-17
CL2004001266A1 (es) 2005-02-04
DE69020755T3 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
ATE124994T1 (de) Physiologisch aktives polypeptid und dna.
FI851336L (fi) Ny fysiologiskt aktiv human polypeptid.
DK163683A (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DE69131514T2 (de) Herstellung von biologisch aktiven rekombinanten Mitgliedern der NGF/BDNF-Familie neurotroper Proteine
NO158950C (no) Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid.
FR2613596B1 (fr) Structure de support de pied, a lanieres en echarpe fixees a la semelle externe d'une chaussure
DE68929551D1 (de) Menschliche DNase
DE3882593D1 (de) Polypeptid und dessen herstellung.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
DE3886175D1 (de) Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt.
IS6072A (is) Æðasamloðunar sameindir og mótun á starfsemi þeirra
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
ATE132900T1 (de) Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität
AR243237A1 (es) Un vector de expresion recombinante que contiene una secuencia de adn que codifica el factor neurotrofico ciliar humano,un microorganismo e.coli transformado,y linea celulares transformadas.
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
DE68918519D1 (de) DNA, welche für ein antikoagulierendes Polypeptid kodiert.
IT8821003A0 (it) Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/ 4 (idrossidifenilmetil) 1piperidinbutanolo".
Burnyasheva et al. On the question of the treatment of urticaria
ATE238780T1 (de) Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung
DK164283C (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat
ATE61817T1 (de) Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
IT8819406V0 (it) Plantare anatomico che permette il massaggio e la respirazione del piede camminando
ATE92106T1 (de) Polypeptid und dessen herstellung.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time